Pituitary and immunology: The Good, the Bad and the Ugly |
|
|
ESE Focus Area Update:
Pituitary and Neuroendocrinology |
Sharing knowledge enabling collaboration |
|
|
Pituitary and immunology: The Good, the Bad and the Ugly
Welcome to the first ESE Focus Area Update for Pituitary and Neuroendocrinology. The Focus Area Updates provide the endocrine community with news, upcoming activities and developments in their areas of interest. The Pituitary and Neuroendocrinology Focus Area Update has been developed by the ESE Focus Area on Pituitary and Neuroendocrinology.
This edition focuses on pituitary tumours, looking at the use of checkpoint inhibitors and the tumour microenvironment. In addition, we highlight some of the available content from ECE 2019, which you can view through ECE On Demand.
Gerald Raverot Guest Editor: ESE Focus Area for Pituitary and Neuroendocrinology
|
|
|
 |
ESE AGHD
Audit Launches We are
pleased to announce the launch of the collection phase of the Pan-European
Adult Growth Hormone Deficiency (AGHD) audit project which aims to collate AGHD
patient data from participating centres to analyse, at the local, national and
European level, the best treatment practices now and in the future. |
|
 |
PAPERS OF INTEREST
Basic/Translational: Driver mutations in USP8 wild type Cushing's disease. Sbiera S, et al., Neuro Oncol. (Jun 2019) Full article Large Genomic Aberrations in Corticotropinomas Are Associated With Greater Aggressiveness. Tatsi C et al., J Clin Endocrinol Metab. (May 2019) Full article Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors. Herrera Martínez AD, et al., Endocr Relat Cancer (Apr 2019) Full article Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade. Lodge EJ, et al., Elife (Mar 2019) Full article Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ. Xekouki P, et al., Endocr Relat Cancer (Jan 2019) Full article Single-Cell RNA Sequencing Reveals Novel Markers of Male Pituitary Stem Cells and Hormone-Producing Cell Types. Cheung LYM, et al., Endocrinology (Dec 2018) Full article
Clinical: Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study. Winzeler B, et al., Lancet (Jul 2019) Full article Determinants of The Growth Hormone Nadir During Oral Glucose Tolerance Test In Adults. Schilbach K, et al., Eur J Endocrinol. (May 2019) Full article Macimorelin as a Diagnostic Test for Adult GH Deficiency. Garcia JM, et al., J Clin Endocrinol Metab. (Aug 2018) Full article
Reviews: Clock genes and cancer development in particular in endocrine tissues. Angelousi A, et al., Endocr Relat Cancer. (Apr 2019) Full article Clinical, pathological and molecular factors of aggressiveness in lactotroph tumours. Trouillas J, Neuroendocrinology. (Apr 2019) Full article Tumor-Directed Therapeutic Targets in Cushing Disease. Theodoropoulou M and Reincke M, J Clin Endocrinol Metab. (Mar 2019) Full article |
|
|
|
CALENDAR 13 - 15 Sep 2019, 7th European Young Endocrine Scientists (EYES) Meeting, Athens, Greece 19 - 21 Sep 2019, 58th Annual ESPE Meeting (ESPE 2019), Vienna, Austria 4 - 6 Oct 2019, 7th Combo Endocrinology International Course, Athens, Greece 10 - 13 Oct 2019, 25th ESE Postgraduate Course, Rotterdam, The Netherlands 16 - 19 Oct 2019, 44th Symposium on Hormones and Cell Regulation, Mont Ste Odile, France 24 - 27 Oct 2019, EndoBridge 2019, Antalya, Turkey 5-7 December 2019, 6th ENEA Workshop: Parasellar Lesions, Athens, Greece 23 - 26 May 2020, 22nd European Congress of Endocrinology, Prague, Czech Republic 9-12 September 2020, 19th Congress of the European Neuroendocrine Association, Porto, Portugal |
|
|
|
|
|
|
